Blockade of central cyclooxygenase (COX) pathways enhances the cannabinoid-induced antinociceptive effects on inflammatory temporomandibular joint (TMJ) nociception

Pain

Volumn 132, Issue 1-2, 2007, Pages 23-32

  Ahn, Dong K ^a   Choi, Hyo S ^a   Yeo, Sang P ^a   Woo, Young W ^a   Lee, Min K ^a   Yang, Gwi Y ^a   Jeon, Hye J ^a   Park, Jae S ^b   Mokha, Sukhbir S ^c  

^a Kyungpook National University   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

^c MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

Antinociception; Cannabinoid; COX inhibitor; Formalin; Hyperalgesia; TMJ

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; FORMALDEHYDE; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PARACETAMOL; PROSTAGLANDIN SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; ENZYME INHIBITION; MALE; MONOTHERAPY; MYOFASCIAL PAIN; NONHUMAN; PRIORITY JOURNAL; RAT; SCRATCHING; SPRAGUE DAWLEY RAT;

ANALGESICS; ANIMALS; ARTHRITIS; CANNABINOIDS; MALE; PAIN MEASUREMENT; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TEMPOROMANDIBULAR JOINT DYSFUNCTION SYNDROME;

EID: 34848861063     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2007.01.015     Document Type: Article

References (55)

1. Ahn D.K., Chae J.M., Choi H.S., Kyung H.M., Kwon O.W., Park H.S., et al. Central cyclooxygenase inhibitors reduced IL-1beta-induced hyperalgesia in temporomandibular joint of freely moving rats. Pain 117 (2005) 205-214
2. Ahn D.K., Kim Y.S., and Park J.S. Central NO is involved in the antinociceptive action of intracisternal antidepressants in freely moving rats. Neurosci Lett 243 (1998) 105-108
3. Ates M., Hamza M., Seidel K., Kotalla C.E., Ledent C., and Guhring H. Intrathecally applied flurbiprofen produces an endocannabinoid-dependent antinociception in the rat formalin test. Eur J Neurosci 17 (2003) 597-604
4. Ayoub S.S., Botting R.M., Goorha S., Colville-Nash P.R., Willoughby D.A., and Ballou L.R. Acetaminophen-induced hypothermia in mice is mediated by a prostaglandin endoperoxide synthase 1 gene-derived protein. Proc Natl Acad Sci USA 101 (2004) 11165-11169
5. Blackburn-Munro G., Bomholt S.F., and Erichsen H.K. Behavioural effects of the novel AMPA/GluR5 selective receptor antagonist NS1209 after systemic administration in animal models of experimental pain. Neuropharmacology 47 (2004) 351-362
6. Bloom A.S., Dewey W.L., Harris L.S., and Brosius K.K. 9-nor-9beta-hydroxyhexahydrocannabinol, a cannabinoid with potent antinociceptive activity: comparisons with morphine. J Pharmacol Exp Ther 200 (1977) 263-270
7. Botting R.M. Mechanism of action of acetaminophen: Is there a cyclooxygenase 3?. Clin Infect Dis 31 (2000) S202-S210
8. Botting R., and Ayoub S.S. COX-3 and the mechanism of action of paracetamol/acetaminophen. Prostaglandins Leukot Essent Fatty Acids 72 (2005) 85-87
9. Buxbaum D.M. Analgesic activity of 9-tetrahydrocannabinol in the rat and mouse. Psychopharmacologia 25 (1972) 275-280
10. Cairns B.E., Sessle B.J., and Hu J.W. Evidence that excitatory amino acid receptors within the temporomandibular joint region are involved in the reflex activation of the jaw muscles. J Neurosci 18 (1998) 8056-8064
11. Cavaletti G., Oggioni N., Sala F., Pezzoni G., Cavalletti E., Marmiroli P., et al. Effect on the peripheral nervous system of systemically administered dimethylsulfoxide in the rat: a neurophysiological and pathological study. Toxicol Lett 118 (2000) 103-107
12. Chandrasekharan N.V., Dai H., Roos K.L., Evanson N.K., Tomsik J., Elton T.S., et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA 99 (2002) 13926-13931
13. Chapman V. Functional changes in the inhibitory effect of spinal cannabinoid (CB) receptor activation in nerve injured rats. Neuropharmacology 41 (2001) 870-877
14. Choi H.S., Ju J.S., Lee H.J., Jung C.Y., Kim B.C., Park J.S., et al. Effects of TNF-alpha injected intracisternally on the nociceptive jaw opening reflex and orofacial formalin test in freely moving rats. Prog Neuropsychopharmacol Biol Psychiatry 27 (2003) 613-618
15. Choi H.S., Ju J.S., Lee H.J., Kim B.C., Park J.S., and Ahn D.K. Effects of intracisternal injection of interleukin-6 on nociceptive jaw opening reflex and orofacial formalin test in freely moving rats. Brain Res Bull 59 (2003) 365-370
16. Choi H.S., Ju J.S., Lim E.J., Lee M.K., Yang C.S., Kim B.C., et al. Intracisternal administration of COX inhibitors enhanced antinociceptive effects of central cannabinoid on formalin-induced TMJ pain in frelly moving rats. Soc Neurosci (2005) Program No. 292.17
17. Choi H.S., Jung S.C., Choi B.J., and Ahn D.K. Intra-articular injection of IL-1β facilitated formalin-induced temporomandibular joint pain in freely moving rats. Korea J Physiol Pharmacol 9 (2005) 23-27
18. Choi H.S., Lee H.J., Jung C.Y., Ju J.S., Kim B.C., Park J.S., et al. Central cyclooxygenase-2 participates in interleukin-1β-induced hyperalgesia in the orofacial formalin test of freely moving rats. Neurosci Lett 352 (2003) 187-190
19. Clavelou P., Dallel R., Orliaguet T., Woda A., and Raboisson P. The orofacial formalin test in rats: effects of different formalin concentrations. Pain 62 (1995) 295-301
20. Clavelou P., Pajot J., Dallel R., and Raboisson P. Application of the formalin test to the study of orofacial pain in the rat. Neurosci Lett 103 (1989) 349-353
21. Cox M.L., and Welch S.P. The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat. Eur J Pharmacol 493 (2004) 65-74
22. Drew L.J., Harris J., Millns P.J., Kendall D.A., and Chapman V. Activation of spinal cannabinoid 1 receptors inhibits C-fibre driven hyperexcitable neuronal responses and increases [35S]GTPgammaS binding in the dorsal horn of the spinal cord of noninflamed and inflamed rats. Eur J Neurosci 12 (2000) 2079-2086
23. Elmes S.J., Jhaveri M.D., Smart D., Kendall D.A., and Chapman V. Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naive rats and in rat models of inflammatory and neuropathic pain. Eur J Neurosci 20 (2004) 2311-2320
24. Fox A., Kesingland A., Gentry C., McNair K., Patel S., Urban L., et al. The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain. Pain 92 (2001) 91-100
25. Guhring H., Hamza M., Sergejeva M., Ates M., Kotalla C.E., Ledent C., et al. A role for endocannabinoids in indomethacin-induced spinal antinociception. Eur J Pharmacol 454 (2002) 153-163
26. Guindon J., De Lean A., and Beaulieu P. Local interactions between anandamide, an endocannabinoid, and ibuprofen, a nonsteroidal anti-inflammatory drug, in acute and inflammatory pain. Pain 121 (2006) 85-93
27. Haas D.A., Nakanishi O., MacMillan R.E., Jordan R.C., and Hu J.W. Development of an orofacial model of acute inflammation in the rat. Arch Oral Biol 37 (1992) 417-422
28. Harada M., Takeuchi M., Fukao T., and Katagiri K. A simple method for the quantitative extraction of dye extravasated into skin. J Pharm Pharmacol 23 (1971) 218-219
29. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., de Costa B.R., and Rice K.C. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 11 (1991) 563-583
30. Herzberg U., Eliav E., Bennett G.J., and Kopin I.J. The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain. Neurosci Lett 221 (1997) 157-160
31. Johnson M.R., Melvin L.S., Althuis T.H., Bindra J.S., Harbert C.A., Milne G.M., et al. Selective and potent analgetics derived from cannabinoids. J Clin Pharmacol 21 (1981) 271S-282S
32. Katori M., and Majima M. Cyclooxygenase-2: its rich diversity of roles and possible application of its selective inhibitors. Inflamm Res 49 (2000) 367-392
33. Kelly S., and Chapman V. Selective cannabinoid CB1 receptor activation inhibits spinal nociceptive transmission in vivo. J Neurophysiol 86 (2001) 3061-3064
34. Kim J., and Alger B.E. Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. Nat Neurosci 7 (2004) 697-698
35. Kis B., Snipes J.A., and Busija D.W. Acetaminophen and the cyclooxygenase-3 puzzle: sorting out facts, fictions, and uncertainties. J Pharmacol Exp Ther 315 (2005) 1-7
36. Kis B., Snipes J.A., Gaspar T., Lenzser G., Tulbert C.D., and Busija D.W. Cloning of cyclooxygenase-1b (putative COX-3) in mouse. Inflamm Res 55 (2006) 274-278
37. Kulkarni S.K., Jain N.K., and Singh A. Cyclooxygenase isoenzymes and newer therapeutic potential for selective COX-2 inhibitors. Methods Find Exp Clin Pharmacol 22 (2000) 291-298
38. Malan Jr. T.P., Ibrahim M.M., Deng H., Liu Q., Mata H.P., Vanderah T., et al. CB2 cannabinoid receptor-mediated peripheral antinociception. Pain 93 (2001) 239-245
39. Martin B.R., Compton D.R., Thomas B.F., Prescott W.R., Little P.J., Razdan R.K., et al. Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs. Pharmacol Biochem Behav 40 (1991) 471-478
40. Martin W.J., Loo C.M., and Basbaum A.I. Spinal cannabinoids are anti-allodynic in rats with persistent inflammation. Pain 82 (1999) 199-205
41. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., and Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346 (1990) 561-564
42. Moss D.E., and Johnson R.L. Tonic analgesic effects of delta 9-tetrahydrocannabinol as measured with the formalin test. Eur J Pharmacol 61 (1980) 313-315
43. Munro S., Thomas K.L., and Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365 (1993) 61-65
44. Papanastassiou A.M., Fields H.L., and Meng I.D. Local application of the cannabinoid receptor agonist, WIN 55,212-2, to spinal trigeminal nucleus caudalis differentially affects nociceptive and non-nociceptive neurons. Pain 107 (2004) 267-275
45. Roveroni R.C., Parada C.A., Cecilia M., Veiga F.A., and Tambeli C.H. Development of a behavioral model of TMJ pain in rats: the TMJ formalin test. Pain 94 (2001) 185-191
46. Samad T.A., Moore K.A., Sapirstein A., Billet S., Allchorne A., Poole S., et al. Interleukin-1β-mediated induction of Cox-2 in the CNS contributes to infammatory pain hypersensitivity. Nature 410 (2001) 425-427
47. Sant G.R., and LaRock D.R. Standard intravesical therapies for interstitial cystitis. Urol Clin North Am 21 (1994) 73-83
48. Scott D.A., Wright C.E., and Angus J.A. Evidence that CB-1 and CB-2 cannabinoid receptors mediate antinociception in neuropathic pain in the rat. Pain 109 (2004) 124-131
49. Smith F.L., Fujimori K., Lowe J., and Welch S.P. Characterization of delta9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats. Pharmacol Biochem Behav 60 (1998) 183-191
50. Sofia R.D., Nalepa S.D., Harakal J.J., and Vassar H.B. Anti-edema and analgesic properties of delta9-tetrahydrocannabinol (THC). J Pharmacol Exp Ther 186 (1973) 646-655
51. Tsou K., Brown S., Sanudo-Pena M.C., Mackie K., and Walker J.M. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83 (1998) 393-411
52. Vinegar R., Truax J.F., Selph J.L., Welch R.M., White H.L., and Ellis C.H. Potentiation of the anti-inflammatory and analgesic activity of aspirin by caffeine in the rat. Proc Soc Exp Biol Med 151 (1976) 556-560
53. Wang X.M., Zhang Z.J., Bains R., and Mokha S.S. Effect of antisense knock-down of alpha(2a)- and alpha(2c)-adrenoceptors on the antinociceptive action of clonidine on trigeminal nociception in the rat. Pain 98 (2002) 27-35
54. Yaksh T.L., and Rudy T.A. Chronic catherization of spinal subarachnoid space. Physiol Behav 17 (1976) 1031-1036
55. Yamamoto T., and Nozaki-Taguchi N. The role of cyclooxygenase-1 and -2 in the rat formalin test. Anesth Analg 94 (2002) 962-967